AIDS (London, England) Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Risk factors for progression from prediabetes to diabetes among older people with HIV..  38:1740-1748. 2024
• Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors..  38:1758-1764. 2024
• Associations between epicardial, visceral, and subcutaneous adipose tissue with diastolic function in men with and without HIV..  38:1485-1493. 2024
• Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America..  38:1366-1374. 2024
• Mediation analysis of CKD risk factors using kidney biomarkers in women living with HIV..  38:813-824. 2024
• PrEP Availability Among Health Facilities Participating in the Global IeDEA Consortium. 2023
• Life course history of physical and sexual abuse is associated with cardiovascular disease risk among women living with and without HIV..  38:739-750. 2023
• Association of urine biomarkers of kidney health with subclinical cardiovascular disease among men with and without HIV..  38:465-475. 2023
• Common antiretroviral combinations are associated with somatic depressive symptoms in women with HIV..  38:167-176. 2023
• Ambulatory urine biomarkers associations with AKI and hospitalization in people with HIV: predictors of acute renal injury study (PARIS)..  37:2339-2348. 2023
• Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer..  37:2049-2057. 2023
• Moving from the prediction of fractures to the prediction of falls in an aging HIV scenario..  37:1467-1469. 2023
• Physical activity is associated with adiposity in older adults with HIV in the modern HIV era..  37:1819-1826. 2023
• Association of marijuana, tobacco and alcohol use with estimated glomerular filtration rate in women living with HIV and women without HIV..  37:1555-1564. 2023
• Tryptophan metabolism, gut microbiota, and carotid artery plaque in women with and without HIV infection..  38:223-233. 2023
• Performance of a modified fracture risk assessment tool (FRAX) for fragility fracture prediction among older veterans living with HIV..  37:1399-1407. 2023
• SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy..  37:F11-F18. 2023
• Hypertension and one-year risk of all-cause mortality among women with treated HIV in the United States..  37:679-688. 2022
• The role of social support on cognitive function among midlife and older adult MSM..  37:803-811. 2022
• Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART..  37:709-721. 2022
• Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection..  37:149-159. 2022
• Mechanisms linking gender-based violence to worse HIV treatment and care outcomes among women in the United States..  36:1861-1869. 2022
• Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus..  36:1801-1809. 2022
• Diet in a global cohort of adults with HIV at Low to Moderate Traditional Cardiovascular Disease Risk..  36:1997-2003. 2022
• Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis..  36:1521-1531. 2022
• Long-term antiretroviral therapy mitigates mortality and morbidity independent of HIV tropism: 18 years follow-up in a women's cohort..  36:1979-1986. 2022
• Hormone therapy and fractures in postmenopausal women..  36:1683-1688. 2022
• Elevated CD4 + T-cell glucose metabolism in HIV+ women with diabetes mellitus..  36:1327-1336. 2022
• Patterns of objectively measured physical activity differ between men living with and without HIV..  36:1553-1562. 2022
• Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States..  36:1095-1103. 2022
• Diabetes mellitus is associated with declines in physical function among men with and without HIV..  36:637-646. 2022
• Molecular profiling of breast and lung cancer in women with HIV reveals high tumor mutational burden..  36:567-571. 2022
• Cardiovascular risk score associations with frailty in men and women with or at risk for HIV..  36:237-347. 2022
• Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection..  36:215-224. 2022
• A new smoking cessation 'cascade' among women with or at risk for HIV infection..  36:107-116. 2022
• A pilot study of microbial signatures of liver disease in those with HIV mono-infection in Rio de Janeiro, Brazil..  36:49-58. 2022
• GlycA is associated with neuropsychological impairment in men with HIV..  36:156-159. 2022
• The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosis..  36:2005-2013. 2022
• Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016.  36:437-445. 2022
• 'Ending the HIV epidemic': where are African American women in the plan?.  35:2541-2544. 2021
• The association of adipose tissue area with subclinical coronary atherosclerosis progression in men with and without HIV..  35:2549-2551. 2021
• The combined effects of age and HIV on the anatomic distribution of cortical and cancellous bone in the femoral neck among men and women..  35:2513-2522. 2021
• HIV serostatus and incident coronary artery stenosis in men with a baseline zero coronary artery calcium..  35:2061-2063. 2021
• HIV, hepatitis C virus and risk of new-onset left ventricular dysfunction in women..  35:1647-1655. 2021
• Risk for incident diabetes is greater in prediabetic men with HIV than without HIV..  35:1605-1614. 2021
• Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/hepatitis C virus coinfected women..  35:1433-1438. 2021
• Tesamorelin improves fat quality independent of changes in fat quantity..  35:1395-1402. 2021
• Low CD4+ cell count nadir exacerbates the impacts of APOE ε4 on functional connectivity and memory in adults with HIV..  35:727-736. 2021
• Mitochondrial DNA haplogroups and weight gain following switch to integrase strand transfer inhibitor-based antiretroviral therapy..  35:439-445. 2021
• Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus nonperinatally acquired HIV..  35:625-632. 2021
• Risk of smoking-related cancers among women and men living with and without HIV..  35:101-114. 2021
• Using health technology to capture digital phenotyping data in HIV-associated neurocognitive disorders..  35:15-22. 2021
• Comparison of dementia risk after age 50 between individuals with and without HIV infection.  35:821-828. 2021
• Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options..  34:2051-2059. 2020
• Syndemic burden and systemic inflammation, HIV health status, and blood pressure among women with unsuppressed HIV viral loads among women living with HIV..  34:1959-1963. 2020
• HIV and risk of dementia in older veterans..  34:1673-1679. 2020
• Elevated cardiac risk score by Atherosclerotic Cardiovascular Disease calculation is associated with albuminuria in older people living with HIV..  34:947-949. 2020
• HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health..  34:699-706. 2020
• All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas..  34:277-289. 2020
• Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma..  34:39-46. 2020
• Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women..  33:2025-2033. 2019
• Poverty stigma is associated with suboptimal HIV care and treatment outcomes among women living with HIV in the United States..  33:1379-1384. 2019
• Evidence-informed practical recommendations for increasing physical activity among persons living with HIV..  33:931-939. 2019
• Plasma acylcarnitines and progression of carotid artery atherosclerosis in HIV infection..  33:1043-1052. 2019
• Effects of HIV viremia on the gastrointestinal microbiome of young MSM..  33:793-804. 2019
• Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women..  33:723-733. 2019
• Frailty predicts fractures among women with and at-risk for HIV..  33:455-463. 2019
• Prevalence and 1-year incidence of frailty among women with and without HIV in the Women's Interagency HIV Study..  33:357-359. 2019
• Virological remission after antiretroviral therapy interruption in female African HIV seroconverters..  33:185-197. 2019
• Global variations in mortality in adults after initiating antiretroviral treatment: an updated analysis of the International epidemiology Databases to Evaluate AIDS cohort collaboration..  33 Suppl 3:S283-S294. 2019
• Non-Hodgkin lymphoma risk in adults living with HIV across five continents..  32:2777-2786. 2018
• Carotid artery atherosclerosis is associated with mortality in HIV-positive women and men..  32:2393-2403. 2018
• Physical function improvements with moderate or high-intensity exercise among older adults with or without HIV infection..  32:2317-2326. 2018
• Abdominal fat depots, insulin resistance, and incident diabetes mellitus in women with and without HIV infection..  32:1643-1650. 2018
• Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV..  32:1257-1266. 2018
• Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ :  CD8+ ratio..  32:1361-1367. 2018
• Metabolic health across the BMI spectrum in HIV-infected and HIV-uninfected men..  32:49-57. 2018
• Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults..  31:2287-2294. 2017
• Antiretroviral initiation is associated with increased skeletal muscle area and fat content..  31:1831-1838. 2017
• Geriatric syndromes: new frontiers in HIV and sarcopenia..  31 Suppl 2:S137-S146. 2017
• Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy..  31:787-795. 2017
• Smoking, HIV, and risk of pregnancy loss..  31:553-560. 2017
• Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection..  31:71-79. 2017
• All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up..  31 Suppl 1:S31-S40. 2017
• Concurrency and HIV transmission network characteristics among MSM with recent HIV infection..  30:2875-2883. 2016
• Long-term body composition changes in antiretroviral-treated HIV-infected individuals..  30:2805-2813. 2016
• Effect of HIV-infection and cumulative viral load on age-related decline in grip strength..  30:2645-2652. 2016
• Associations between antiretroviral use and subclinical coronary atherosclerosis..  30:2477-2486. 2016
• Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and HIV-uninfected men..  30:2075-84. 2016
• CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy..  30:899-908. 2016
• Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV..  30:609-18. 2016
• Long-term impact of HIV wasting on physical function..  30:445-54. 2016
• Incidence and progression of coronary artery calcium in HIV-infected and HIV-uninfected men..  29:2427-34. 2015
• The relationship of physical performance with HIV disease and mortality: authors' response..  29:751-3. 2015
• Effects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adults..  29:175-82. 2015
• The relationship of physical performance with HIV disease and mortality..  28:2711-9. 2014
• Relationship of physical function and quality of life among persons aging with HIV infection..  28:1939-43. 2014
• Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis..  28:1635-44. 2014
• Impact of randomized antiretroviral therapy initiation on glucose metabolism..  28:1451-61. 2014
• A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans..  28:1289-95. 2014
• Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men..  28:901-9. 2014
• Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection..  28:841-9. 2014
• Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women..  28:59-66. 2014
• HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection..  28:49-58. 2014
• Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women..  27:2291-9. 2013
• Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density..  27:2069-79. 2013
• Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection..  27:1921-31. 2013
• Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans..  27:1339-43. 2013
• Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART..  27:573-8. 2013
• Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection..  25:1405-14. 2011
• Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons..  25:1289-98. 2011
• Multiple independent lineages of HIV-1 persist in breast milk and plasma..  25:143-52. 2011
• Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study..  24:2679-86. 2010
• Prospective study of bone mineral density changes in aging men with or at risk for HIV infection..  24:2337-45. 2010
• Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy..  24:1717-26. 2010
• Seronegative HIV-1 infection: a review of the literature..  24:1407-14. 2010
• Using highly active antiretroviral therapy to decrease perioperative HIV-1 transmission risk..  24:1603-4; author reply 1604. 2010
• A genome-wide association study of carotid atherosclerosis in HIV-infected men..  24:583-92. 2010
• Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study..  23:1841-9. 2009
• HIV viremia and changes in kidney function..  23:1089-96. 2009
• Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study..  22:1589-99. 2008
• Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals..  22:489-96. 2008
• HIV-associated neuromuscular weakness syndrome..  18:1403-12. 2004
• Low food security is associated with frailty status and frailty components among people with HIV.
• Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016 2022
• Comparison of dementia risk after age 50 between individuals with and without HIV infection 2021

Identity

International Standard Serial Number (ISSN)

• 0269-9370
• 1473-5571